Gene · 5817
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy. | J Exp Clin Cancer Res | 2025 | 41233805 | PubTator, text mining | PubMed |
| Human stem cell-derived β cells expressing an optimized CD155 reduce cytotoxic immune cell function for application in type 1 diabetes. | Sci Adv | 2025 | 41202120 | PubTator, text mining | PubMed |
| CD155-TIGIT/CD96/CD226 immune checkpoint axis interacting with tumor-infiltrating lymphocytes to exhibit diverse prognostic effects on breast cancer: a cohort study. | Front Immunol | 2025 | 41181119 | PubTator, text mining | PubMed |
| Qingre huazhuo tang regulates IgA nephropathy through immune checkpoints and ferroptosis. | J Tradit Complement Med | 2025 | 41169938 | PubTator, text mining | PubMed |
| Inter-Eye Molecular Discrepancies in the Corneal Epithelium Point to TFRC in the Keratoconus Severity Signature and Mechanism of Cone Formation. | Invest Ophthalmol Vis Sci | 2025 | 41159650 | PubTator, text mining | PubMed |
| The predictive effect of the CD155-TIGIT immune checkpoint axis complex on neoadjuvant chemotherapy efficacy in triple-negative breast cancer: A preliminary study. | Cancer Biomark | 2025 | 41134836 | PubTator, text mining | PubMed |
| Expression Modulation of Immune Inhibitory Molecules by Small Molecule Inhibitor Drugs in Leukemic Cells of Chronic Lymphocytic Leukemia. | Iran J Pharm Res | 2025 | 41104252 | PubTator, text mining | PubMed |
| Enhancing anti-tumor immunity through TIGIT blockade and tumor-directed targeting in pancreatic cancer. | Int Immunopharmacol | 2025 | 41101232 | PubTator, text mining | PubMed |
| The Development of Monoclonal Antibodies Specific to the Soluble Form of CD155 in the Human Peripheral Blood. | Monoclon Antib Immunodiagn Immunother | 2025 | 41090489 | PubTator, text mining | PubMed |
| Corrigendum to "CD155 blockade improves survival in experimental sepsis by reversing dendritic cell dysfunction" [Biochem. Biophys. Res. Commun. 490 (2017) 283-289]. | Biochem Biophys Res Commun | 2025 | 41087272 | PubTator, text mining | PubMed |
| Establishment and validation of the prediction model based on lymphocyte subsets for acute kidney injury in sepsis patients. | Front Immunol | 2025 | 41080572 | PubTator, text mining | PubMed |
| Scientometric analysis of extracellular vesicles in vision science (up to 2024). | J Nanobiotechnology | 2025 | 41074034 | PubTator, text mining | PubMed |
| A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma. | Nat Cancer | 2025 | 41057692 | PubTator, text mining | PubMed |
| Post-Polio Syndrome: Impact of Humoral Immune Deficiencies, Poliovirus Neutralizing Antibodies, Vitamin D Deficiency. | Vaccines (Basel) | 2025 | 41012142 | PubTator, text mining | PubMed |
| ZNF180 modulates tumor intrinsic immunotherapy resistance in melanoma through driving plasticity. | bioRxiv | 2025 | 41000822 | PubTator, text mining | PubMed |
| Lung NR3C1+ and CXCR6high T cells distinguish immunopathogenesis of human emphysema. | Commun Biol | 2025 | 40993192 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to CAR T-Cells and How to Overcome Them. | Methods Protoc | 2025 | 40981226 | PubTator, text mining | PubMed |
| Advancing our understanding of the influence of myeloid-derived suppressor cells in chronic myeloid leukemia. | J Cancer Res Clin Oncol | 2025 | 40970984 | PubTator, text mining | PubMed |
| Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity. | Proc Natl Acad Sci U S A | 2025 | 40966292 | PubTator, text mining | PubMed |
| Monocyte/macrophage-derived interleukin-15 mediates the pro-inflammatory phenotype of CD226+ B cells in type 1 diabetes. | EBioMedicine | 2025 | 40957221 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5817/papers?page=11